Article
Polymorphisms in CYP3A5, CYP3A4, and ABCB1 are not associated with cyclosporine pharmacokinetics nor with cyclosporine clinical end points after renal transplantation.
Therapeutic drug monitoring - 1 Apr 2011
Bouamar Rachida, Hesselink Dennis A, van Schaik Ron H N, Weimar Willem, Macphee Iain A M, de Fijter Johan W, van Gelder Teun
Abstract excerpt
BACKGROUND: The association of CYP3A5, CYP3A4, and ABCB1 single nucleotide polymorphisms (SNPs) with cyclosporine (CsA) pharmacokinetics is controversial. The authors studied the influence of these SNPs on CsA pharmacokinetics as well as on the incidence of biopsy-proven acute rejection (BPAR) an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
